Cancer Immunotherapy

被引：5

作者：

Bergman, Philip J. ^{[1
,2
]}

机构：

[1] BrightHeart Vet Ctr, Armonk, NY 10504 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA

来源：

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE | 2010年 / 40卷 / 03期

关键词：

Cancer; Vaccine; Immunotherapy; Tumor; ENCAPSULATED MURAMYL TRIPEPTIDE; REGULATORY T-CELLS; SPONTANEOUS CANINE MELANOMA; COLONY-STIMULATING FACTOR; BIOLOGICAL RESPONSE MODIFIERS; RECOMBINANT FELINE INTERFERON; MEDIATED IMMUNE-RESPONSES; IMIQUIMOD 5-PERCENT CREAM; BACILLUS-CALMETTE-GUERIN; SOFT-TISSUE SARCOMA;

D O I：

10.1016/j.cvsm.2010.01.002

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

The veterinary oncology profession is uniquely able to contribute to the many advances that are imminent in immunotherapy. However, what works in a mouse will often not reflect the outcome in human patients with cancer. Therefore, comparative immunotherapy studies using veterinary patients may be better able to bridge murine and human studies. Many cancers in dogs and cats seem to be stronger models for their counterpart human tumors than presently available murine model systems. This author looks forward to the time when immunotherapy plays a significant role in the treatment and/or prevention of cancer in human and veterinary patients.

引用

页码：507 / +

页数：13

共 100 条

[11] An allogeneic hybrid-cell fusion vaccine against canine mammary cancer [J].

Bird, R. Curtis ;

DeInnocentes, Patricia ;

Lenz, Steven ;

Thacker, Erin E. ;

Curiel, David T. ;

Smith, Bruce F. .

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 123 (3-4) :289-304

[12] Immunosuppressive cytokines in the regional lymph node of a dog suffering from oral malignant melanoma [J].

Catchpole, B ;

Gould, SM ;

Kellett-Gregory, LM ;

Dobson, JM .

JOURNAL OF SMALL ANIMAL PRACTICE, 2002, 43 (10) :464-467

[13] Tumor resistance to specific lysis: A major hurdle for successful immunotherapy of cancer [J].

Chouaib, Salem ;

Mestin, Franck ;

Thiery, Jerome ;

Mami-Chouaib, Fathia .

CLINICAL IMMUNOLOGY, 2009, 130 (01) :34-40

[14] Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model [J].

Chuang, Tien-Fu ;

Lee, Shan-Chih ;

Liao, Kuang-Wen ;

Hsiao, Ya-Wen ;

Lo, Chia-Hui ;

Chiang, Bor-Luen ;

Lin, Xi-Zhang ;

Tan, Mi-Hua ;

Chu, Rea-Min .

INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) :698-707

[15]

Cutrera Jeffry, 2008, V423, P319, DOI 10.1007/978-1-59745-194-9_24

[16]

Dickerson EB, 2004, MOL CANCER RES, V2, P663

[17] Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer [J].

Dickerson, KB ;

Fosmire, S ;

Padilla, ML ;

Modiano, JF ;

Helfand, SC .

JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01) :36-45

[18] Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases [J].

Dow, S ;

Elmslie, R ;

Kurzman, I ;

MacEwen, G ;

Pericle, F ;

Liggitt, D .

HUMAN GENE THERAPY, 2005, 16 (08) :937-946

[19] In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma [J].

Dow, SW ;

Elmslie, RE ;

Willson, AP ;

Roche, L ;

Gorman, C ;

Potter, TA .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2406-2414

[20] Leveraging the activity of tumor vaccines with cytotoxic chemotherapy [J].

Emens, LA ;

Jaffee, EM .

CANCER RESEARCH, 2005, 65 (18) :8059-8064

← 1 2 3 4 5 6 7 8 9 10 →